Skip to search formSkip to main contentSkip to account menu

Triptorelin

Known as: triptorelina, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2, TRIP 
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin… 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (3)

AY-25650DecapeptylTriptorelin Acetate
NCIt Antineoplastic Agent TerminologyTriptorelin 22.5 MG InjectionTriptorelin Acetate 100 ug in 1 mL VAGINAL GEL [OvuGel]cyproterone/triptorelin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
BACKGROUND Heavy menstrual bleeding is one of the most common reasons for referral of premenopausal women to a gynaecologist… 
2010
2010
Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline
Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer… 
2007
2007
Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation.
2002
2002
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
Highly Cited
1990
Highly Cited
1990
Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
Highly Cited
1990
Highly Cited
1990
Inhibitory effects of analogs of luteinizing hormone‐releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regression
Syrian golden hamsters bearing N‐nitrosobis(2‐oxopropyl)amine (BOP)‐induced pancreatic carcinomas were treated for 2 months with… 
1990
1990
Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
Groups of 15 female Syrian golden hamsters with N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancers were treated for 2 mo… 
1990
1990
GnRH receptors in rat brain, pituitary and testis; modulation following surgical and gonadotropin-releasing hormone agonist-induced castration
1989
1989
Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer.
Review
1988
Review
1988
Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules.
Forty-one patients with advanced ovarian cancer (FIGO stage III or IV) who had relapsed following conventional treatment were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)